Compare Humana Inc (HUM) vs ProShares Ultra Gold ETF (UGL) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Humana Inc vs ProShares Ultra Gold ETF — how do they compare? Humana Inc trades at $403.17 (market cap $47.81B), while ProShares Ultra Gold ETF trades at $44.63. The key difference: Humana Inc pays a 0.89% dividend while ProShares Ultra Gold ETF pays none, and Humana Inc is trading nearer its 52-week high, ProShares Ultra Gold ETF nearer its low. Which is the better fit depends on your goals.
| HUM | UGL | |
|---|---|---|
Market Cap | $47.81B | — |
Sector | Health | Leveraged / Inverse |
52-Week High | $409.42 | $85.62 |
52-Week Low | $163.67 | $33.59 |
Enterprise Value | $56.85B | — |
Dividend Yield | 0.89% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Humana (HUM) trades at $398.09, down 0.48% with a bullish technical signal from moving averages. The company shows strong revenue growth to $129.66B in 2025 but faces margin compression with net income margin declining to 0.82%. Recent earnings have consistently beaten expectations, and analyst sentiment is mixed with 34% buy ratings but a consensus price target of $354.33 below current levels.
The outlook suggests cautious optimism with Medicare Advantage expansion opportunities but significant margin pressure and regulatory risks. Key investment considerations include the company's ability to achieve its 3% Medicare Advantage margin target by 2028 while navigating increased healthcare utilization costs and competitive pressures in the insurance sector.
UGL, the ProShares Ultra Gold ETF, trades at $43.39, down 0.41% amid bearish technical signals. The leveraged ETF faces pressure from higher interest rate expectations and a stronger dollar, with gold struggling to hold the $4,000 support level. Recent news highlights mixed sentiment, with Wall Street bearish on near-term gold prospects but long-term structural drivers like central bank buying remaining intact.
Outlook remains cautious as UGL's performance hinges on gold price volatility and Fed policy. Risks include leveraged decay and macroeconomic shifts, while opportunities exist if gold resumes its bull trend. Investors should weigh the ETF's high sensitivity to daily gold moves against current bearish technical and sentiment indicators.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Humana Inc
Humana is one of the largest private health insurers in the U.S. with a focus on administering Medicare Advantage plans. The firm has built a niche specializing in government-sponsored programs, with nearly all its medical membership stemming from individual and group Medicare Advantage, Medicaid, and the military's Tricare program. The firm is also a leader in stand-alone prescription drug plans for seniors enrolled in traditional fee-for-service Medicare. Humana offers employer-based plans primarily for small businesses along with specialty insurance offerings such as dental, vision, and life. Beyond medical insurance, the company provides other healthcare services, including primary-care services, at-home services, and pharmacy benefit management.
Read more on HUM →About ProShares Ultra Gold ETF
UGL is a leveraged ETF that seeks daily investment results, before fees and expenses, that correspond to two times (2x) the daily performance of the Bloomberg Gold Subindex. It is a tactical tool designed for sophisticated investors to magnify short-term bullish views on gold prices through the use of futures and swap contracts, rather than holding physical bullion.
Read more on UGL →
